Having used our molecular analysis to distinguish independent primary tumors from metastatic recurrences in the setting of familial EGFR-mutant lung cancer, we turned to a separate cohort of ten apparently sporadic cases with multiple EGFR-mutant lesions. This evidence concerns the gene EGFR and lung cancer.